Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 30, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.9K

Reply: To PMID 25442983

Rachel E Sunstrom1, Stephen M Langley2

  • 1Doernbecher Children's Hospital, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd, Portland, OR97239.

The Annals of Thoracic Surgery
|November 3, 2015
PubMed
Summary

No abstract available in PubMed .

More Related Videos

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging
05:51

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging

Published on: March 17, 2023

2.4K
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

1.7K

Related Experiment Videos

Last Updated: Mar 30, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.9K
A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging
05:51

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging

Published on: March 17, 2023

2.4K
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

1.7K

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Double trouble: double aortic arch with bilateral interruption and bilateral arterial ducts.

Cardiology in the young·2026
Same author

Surgical Quality Predicts Length of Stay in Patients with Congenital Heart Disease.

Pediatric cardiology·2016
Same author

Fetal ventricular interactions and wall mechanics during ductus arteriosus occlusion in a sheep model.

Ultrasound in medicine & biology·2015
Same author

Abnormal myocardial blood flow in children with mild/moderate aortic stenosis.

Cardiology in the young·2015
Same author

High flow velocity through congenital cardiac lesions predicts preoperative platelet dysfunction.

The Annals of thoracic surgery·2015
Same author

A defined management strategy improves early outcomes after the Fontan procedure: the PORTLAND protocol.

The Annals of thoracic surgery·2014
Same journal

Context-Driven Management of Bilateral Diaphragmatic Failure After Phrenic Nerve Sacrifice.

The Annals of thoracic surgery·2026
Same journal

Uncomplicated type B aortic dissection: Are US-based societal guidelines delaying science?

The Annals of thoracic surgery·2026
Same journal

Methodological Paradigms and Clinical Realities in Defining High-Volume Centres for Valve-Sparing Aortic Root Replacement.

The Annals of thoracic surgery·2026
Same journal

Long-Term Outcomes of Concomitant Atrial Fibrillation Management During CABG: Standardization or Compromise?

The Annals of thoracic surgery·2026
Same journal

Ongoing Dialogue and Support for the Future of Congenital Cardiac Surgery.

The Annals of thoracic surgery·2026
Same journal

A Bridge With Gaps.

The Annals of thoracic surgery·2026
See all related articles